Oric Pharmaceuticals stock trades up as price holds above key supports despite mixed momentum

Traders Union
All News
Business & Wealth
Companies
Oric Pharmaceuticals up 0.32% today

Highlights

ORIC is trading above short- and medium-term moving averages but remains below its long-term resistance, signaling unresolved overhead supply.
Bullish momentum has dominated recently, driving an 11.4% weekly gain, yet mixed indicators and overbought signals warn of near-term exhaustion.
Expected price action this week is a sideways move between $9.70 and $10.00, with downside more likely unless strong resistance at $10.15 is broken.

The company says the effort supported families and helped address food insecurity in the community. Oric Pharmaceuticals states it is proud to give back and help strengthen the communities it serves.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish posture above short-term averages as long-term resistance persists

ORIC is trading at $9.46, well above the SMA-20 ($8.33) and SMA-50 ($8.94), suggesting a short- and medium-term bullish bias, yet below the SMA-200 ($10.67), highlighting lingering long-term resistance. The Ichimoku Kijun at $8.64 serves as immediate support, with near-term support at the SMA-50 ($8.94) and key support at the SMA-20 ($8.33), while immediate resistance is the SMA-100 ($10.15) and key resistance is the SMA-200 ($10.67).

Mixed momentum signals as overbought readings temper recent rally

Momentum signals are mixed: MACD on D1 is neutral, and ADX (15.91) shows weak trend strength. RSI on D1 is above 60 with a "Buy" signal, but Stoch RSI and CCI are both in overbought territory, warning of short-term exhaustion. BBP on D1 is positive at 1.26, indicating buyers currently dominate, and the Awesome Oscillator also supports upside momentum. ORIC is trading at $9.46, up sharply from $8.49 a week ago, reflecting an 11.4% gain as it holds in the upper part of the weekly range. Weekly volatility stands at 14.76%, and the tone is one of recovery with momentum not fully confirmed by all oscillators.

Downside risk takes precedence as upward momentum fades

For the coming week, the expected price range is $9.68 to $10.07. This keeps the price anchored between the 52-week low ($7.32) and high ($14.93), yet close to recent highs. Based on W1 signals—RSI ("Sell"), ADX ("Neutral"), MACD ("Sell"), and MA-50 ("Sell")—the probability of further price increases is very low (less than 20%), making downside movement more likely. Baseline scenario: price oscillates sideways between $9.70 and $10.00. Bullish scenario: a close above resistance ($10.15) could trigger a move towards $10.50. Bearish scenario: a drop below near-term support ($8.94) could lead to a retest of $8.60–$8.30.

Earlier, analysts noted that Oric Pharmaceuticals was facing continued downward pressure, with limited prospects for a sustained near-term rebound. In light of current developments, investors should watch for any decisive trend shifts or breakouts that could redefine the prevailing scenario.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.